Information for Applicants

CIRM has compiled the following resources to support you and your institution in the application process. Please be sure to read all relevant guidelines and requirements before submitting your application.


Data Sharing and Management  

As articulated in CIRM’s 2022-2027 strategic plan, CIRM is committed to building infrastructure that organizes and democratizes data through knowledge networks that foster a culture of open science and advance novel, discovery, translational and clinical research approaches. The CIRM knowledge networks will facilitate effective management, standardization, sharing and collaborative analysis of CIRM-funded research data. 

As an important step toward realizing this goal, CIRM requires that data generated using CIRM funds is shared using FAIR principles. Please consult the Data Sharing and Management Plan (DSMP) Guidelines for CIRM data sharing requirements and guidance on how to prepare a DSMP for a CIRM application.   


Clinically Compatible hPSC lines for Therapeutic Development and Commercialization

Any applicant who intends to develop an allogeneic human pluripotent stem cell (hPSC)-derived therapeutic with CIRM funding must establish evidence of disease/injury modifying activity using a clinically compatible cell source that can be translated for clinical use. An applicant should plan to select a clinically compatible hPSC line to establish this data during the course of a DISC2 award or must have already established this data if applying for TRAN1 or CLIN1.